All PlansCoverageMedium impact
Newsletter Vol. 8, No. 37
New Jersey Medicaid·Orthopedics, Rheumatology, Sports Medicine +1 more·Medical Policy
We identified it
Jun 20, 2026
Summary
This policy update covers viscosupplementation treatments using Synvisc and Hyalgan for knee osteoarthritis. Since only a summary is available, specific coverage criteria, billing requirements, or prior authorization changes cannot be determined without the full policy document.
Action Required
Immediately: Access the full policy document at https://www.njmmis.com/documentDownload.aspx?document=8-37.pdf to review complete coverage criteria for viscosupplementation procedures. Billing team must verify current prior authorization requirements, covered codes, and documentation requirements for Synvisc and Hyalgan injections before processing claims.